⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
VTGN
ZYXIQ CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
globenewswire.com
VTGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – VTGN
globenewswire.com
VTGN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Vistagen Therapeutics, Inc. (VTGN) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
VTGN
Pomerantz LLP Advises Investors of Class Action Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Form 8-K
sec.gov
VTGN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 16, 2026 in Vistagen Therapeutics, Inc. Lawsuit – VTGN
globenewswire.com
VTGN
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
VTGN
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline Tonight
businesswire.com
VTGN
Pomerantz LLP Advises Investors of Class Action Filing Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN